“This award belongs to our dedicated team of employees who always put the patient first – we are grateful to them, and we are very pleased to accept this award from MedTech Breakthrough.” – Kevin Kenny, President of Orthofix Global Spine

LOS ANGELES (PRWEB)
May 04, 2023

MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies and products in the global health and medical technology market, today announced that Orthofix, a global medical device company with a spine and orthopedics focus, has been selected as winner of the “Best Patient Engagement Mobile App” award in the 7th annual MedTech Breakthrough Awards program. The award recognizes the breakthrough innovation of the Orthofix STIM onTrack™ mobile app.

Developed to work with the latest generation CervicalStim™, SpinalStim™, and PhysioStim™ bone growth therapy devices, the STIM onTrack mobile app is designed to help patients adhere to their prescriptions and improve their clinical outcomes. For use with smartphones and other mobile devices, the app features include daily treatment reminders and device usage calendars to help patients stay on schedule with their therapy. Additionally, the app enables the sharing of treatment data and includes a patient reported outcome measure questionnaire (PROM). These responses are available to physicians in order to assist in understanding current treatment progress and overall recovery status for their patients.

“We are very proud of the STIM onTrack app and the work that went into developing this tool to assist patients in their recovery efforts,” said Kevin Kenny, President of Orthofix Global Spine. “This award belongs to our dedicated team of employees who always put the patient first – we are grateful to them, and we are very pleased to accept this award from MedTech Breakthrough.”

The STIM onTrack mobile app also provides links to educational patient resources and connects patients with a Patient Care team to help ensure patients understand their treatment regimens. Orthofix was the first to bring to market a patient mobile app for bone growth stimulation devices.

The mission of the MedTech Breakthrough Awards is to honor excellence and recognize the innovation, hard work and success in a range of health and medical technology categories, including Telehealth, Clinical Administration, Patient Engagement, Electronic Health Records (EHR), Virtual Care, Medical Devices, Medical Data and many more. This year’s program attracted more than 4,000 nominations from over 17 different countries throughout the world.

“Research has shown that patients who take a more active role in their recovery and follow-up care have better overall outcomes. Digitizing care on a mobile app takes a familiar device – our phones – and provides a beneficial pathway for patients to adhere to treatment. Medical technology advancements can and should be designed to improve patient outcomes,” said James Johnson, managing director, MedTech Breakthrough. “STIM onTrack allows patients to actively engage in their own treatment plan, and the addition of the PROM questionnaire enables their providers to gain even more insight on how a patient is responding in real time, not just when they come in for a follow up. We extend our sincere congratulations to the entire Orthofix team for taking home a well-deserved 2023 MedTech Breakthrough Award.”

####

About MedTech Breakthrough

Part of Tech Breakthrough, a leading market intelligence and recognition platform for global technology innovation and leadership, the MedTech Breakthrough Awards program is devoted to honoring excellence and innovation in medical and health technology companies, products, services and people. The MedTech Breakthrough Awards provide a platform for public recognition around the achievements of breakthrough healthcare and medical companies and products in categories that include Patient Experience and Engagement, Health and Fitness, Medical Devices, Clinical Administration, Connected Healthcare, Medical Data, Healthcare Cybersecurity and more. For more information, visit MedTechBreakthrough.com.

About Orthofix

The newly merged Orthofix-SeaSpine organization is a leading global spine and orthopedics company with a comprehensive portfolio of biologics, innovative spinal hardware, bone growth therapies, specialized orthopedic solutions and a leading surgical navigation system. Its products are distributed in approximately 68 countries worldwide.

The Company is headquartered in Lewisville, Texas and has primary offices in Carlsbad, CA, with a focus on spine and biologics product innovation and surgeon education, and Verona, Italy, with an emphasis on product innovation, production, and medical education for orthopedics. The combined company’s global R&D, commercial and manufacturing footprint also includes facilities and offices in Irvine, CA, Toronto, Canada, Sunnyvale, CA, Wayne, PA, Olive Branch, MS, Maidenhead, UK, Munich, Germany, Paris, France and São Paulo, Brazil. For more information, please visit Orthofix.com.

Share article on social media or email: